LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
LY2801653 是一种口服生物可利用的多激酶抑制剂,对 MET、MST1R 和其他癌蛋白具有强效活性,并在小鼠异种移植模型中表现出抗肿瘤活性
期刊:Investigational New Drugs
影响因子:3
doi:10.1007/s10637-012-9912-9
S Betty Yan, Victoria L Peek, Rose Ajamie, Sean G Buchanan, Jeremy R Graff, Steven A Heidler, Yu-Hua Hui, Karen L Huss, Bruce W Konicek, Jason R Manro, Chuan Shih, Julie A Stewart, Trent R Stewart, Stephanie L Stout, Mark T Uhlik, Suzane L Um, Yong Wang, Wenjuan Wu, Lei Yan, Wei J Yang, Boyu Zhong,